Antimicrobial-resistant infections
From the Journals
Rate of resistant P. aeruginosa in children rising steadily
The rate of infection with resistant Pseudomonas aeruginosa among children has risen steadily by 4% annually since 1999.
Conference Coverage
‘Skip phenomenon’ could explain fluctuating positivity for S. aureus bacteremia
NEW ORLEANS – Some patients treated appropriately with antibiotics for Staphylococcus aureus bacteremia can generate a negative blood culture...
Conference Coverage
Infectious disease physicians: Antibiotic shortages are the new norm
Antibiotic shortages are now a way of life, and physicians report that shortages are affecting patient care and outcomes.
Conference Coverage
Behavioral interventions durably reduced inappropriate antibiotic prescribing
NEW ORLEANS – A behavioral intervention that involves “social motivation” appears to promote durable beneficial effects on antibiotic prescribing...
Conference Coverage
Novel antibiotic hits skin and soft tissue infections with one-two punch
NEW ORLEANS – A novel antibiotic in development fared well in terms of efficacy and safety for patients hospitalized for suspected or confirmed...
News from the FDA/CDC
CDC: Seven cases of multidrug resistant C. auris have occurred in United States
The CDC has reported seven cases of the multidrug-resistant fungal infection Candida auris in the United States, all in health care settings.
Conference Coverage
Treated bacteremia that clears, then recurs, termed ‘skip phenomenon’
S. aureus
From the Journals
CDC study finds worrisome trends in hospital antibiotic use
U.S. hospitals have not cut overall antibiotic use and have significantly increased the use of several broad-spectrum agents, according to a first...
From the Journals
E. coli resistant to colistin and carbapenems found in U.S. patient
The first strain of Escherichia coli harboring the antibiotic-resistant genes mcr-1 and blaNDM-5 ...
Commentary
Striking the balance: Who should be screened for CP-CRE acquisition?
Identifying which patients are at high risk of acquiring carbapenem-resistant Enterobacteriaceae (CRE) is important to prevent further...
News
Ceftazidime-avibactam stands up to CRE, but resistance a problem
Intravenous ceftazidime-avibactam successfully treated 59% of carbapenem-resistant Enterobacteriaceae (CRE) infections, and 76% of patients...